article thumbnail

Polypharmacy Case Study – Sleepers, Diabetes, and More

Med Ed 101

In this polypharmacy case study, we review a medication list and try to identify areas to reduce medications and avoid adverse reactions. EK is a 66-year-old female with a past medical history of insomnia, diabetes, GERD, hypertension, hyperlipidemia, obesity, recurrent UTI, and osteoarthritis.

article thumbnail

First cell therapy approved for Type 1 diabetes

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Lantidra, the first cell therapy for certain adults with Type 1 diabetes. In some Type 1 diabetes patients, these infused cells can produce enough insulin. Therefore the patient does not need to continue to take insulin by injections or pump to control blood sugar levels.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA, Novo Nordisk Warn of Counterfeit Semaglutide Injection Pens

Pharmacy Times

A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.

article thumbnail

CellTrans’ Lantidra Receives the US FDA’s Approval for the Treatment of Type 1 Diabetes

PharmaShots

11 for 1-5yrs. & 10 for ≥5yrs. Your go-to media platform for customized news ranging for multiple indications.

article thumbnail

Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19: Study

Express Pharma

There were some significant variations between the two areas, though, such as India’s lower weight and its higher use of antivirals and other therapies; also the higher proportion of patients with Diabetes in India. Serious adverse reactions: Regarding serious adverse reactions (SARs), an interesting finding was made.

article thumbnail

How can evidence-based medicine (EBM) methodology support drug withdrawals?

European Pharmaceutical Review

1 But while data on adverse reactions is rightly used to help with these decisions, there is currently no additional modelling on the positive impact regulatory action could have on public health. The types of adverse drug reactions examined included low blood pressure, diabetes, cancer, bleeding, involuntary movements and weight loss.

article thumbnail

GLP-1 Receptor Agonists

RX Note

They are used in patients with type 2 diabetes in combination with other drugs (such as metformin, sulfonylurea and insulin). Adverse Reactions All GLP-1 receptor agonists have been associated with nausea and other gastrointestinal disturbances.